Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies-Reference-Cited by-同舟云学术

Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies

Published:2021-01 Issue:1 Volume:48 Page:875-886
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Dib Israa,Khalil Alia,Chouaib Racha,El-Makhour Yolla,Noureddine Hiba

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-020-06071-5.pdf

Reference100 articles.

1. Castellano JM, Narula J, Castillo J et al (2014) Promoting cardiovascular health worldwide: strategies, challenges, and opportunities. Rev Esp Cardiol (Engl Ed) 67(9):724–730

2. Mc Namara K, Alzubaidi H, Jackson JK (2019) Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract 4(8):1–11

3. Hajar R (2016) Framingham contribution to cardiovascular disease. Heart Views 17(2):78–81

4. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442

5. Palomaki GE, Melillo S, Neveux L et al (2010) Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies–a targeted evidence-based review. Genet Med 12(12):772–784

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Apolipoprotein C-III for the Management of Severe Hypertriglyceridemia: Current Research and Future Directions;Cureus;2024-08-17

2. Blood Plasma Markers in Depressed Mice under Chronic Social Defeat Stress;Biomedicines;2024-07-05

3. Advances in nucleic acid-targeted therapies for cardiovascular disease prevention;Cardiovascular Research;2024-07

4. Loss of genetic diversity and isolation by distance and by environment in populations of a keystone ungulate species;Conservation Genetics;2024-04-03

5. Contractile and Genetic Characterization of Cardiac Constructs Engineered from Human Induced Pluripotent Stem Cells: Modeling of Tuberous Sclerosis Complex and the Effects of Rapamycin;Bioengineering;2024-02-28